pulmonary tb. by prof. azza el- medany department of pharmacology

48
Pulmonary TB

Upload: justin-page

Post on 16-Jan-2016

219 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Pulmonary TB

Page 2: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

BY

PROF.

AZZA EL- MEDANY

Department of Pharmacology

Page 3: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

OBJECTIVES

At the end of lecture , the students should: Discuss the etiology of tuberculosis Discuss the common route for transmission of the

disease Discusses the out line for treatment of tuberculosis Discuss the drugs used in the first & second line

Page 4: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

OBJECTIVES ( continue)

Regarding : The mechanism of action Adverse effects Drug interactions Contraindication Discuss tuberculosis & pregnancy Discuss tuberculosis & breast feeding

Page 5: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

EtiologyMycobacterium tuberculosis, an acid fast bacillus

with three types known to infect man causing pulmonary TB:The human type, commonestThe bovine typeThe african type

Page 6: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Robert Koch was the first

to see Mycobacterium tuberculosis with his staining technique in 1882.

Page 7: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

•Each Each

year, 1% year, 1%

of the of the

global global

population population

is is

infected. infected.

   Disease information:Disease information:

Page 8: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology
Page 9: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology
Page 10: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology
Page 11: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Tuberculosis

Common sites of infections Apical areas of lung Renal parenchyma Growing ends of bones

Where oxygen tension is high

Page 12: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Treatment Of Tuberculosis

Preventing drug resistance is the most important reason to use drug combination.

Periods of treatment ( minimum 6 months)Drugs are divided into two groups:

1. First line 2. Second line

Page 13: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Antimycobacterial drugs

First line Isoniazid (INH)RifampinEthambutolStreptomycinPyrazinamide

Page 14: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Never use a single drug therapy

Isoniazid –rifampin combination administered for 9 months will cure 95-98% of cases .

Addition of pyrazinamide for this combination for the first 2 months allows total duration to be reduced to 6 months.

Page 15: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Isoniazid ( INH)

Bactericidal Is effective against intracellular

& extracellular bacilli

Page 16: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Mechanism Of Action

Inhibits the synthesis of mycolic acid

( inhibits bacterial cell wall )

Page 17: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Clinical usesTreatment of TB .Treatment of Latent tuberculosis in patients

with positive tuberculin skin test

Prophylaxis against active TB in individuals who are in great risk .

Page 18: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Adverse effects

Peripheral neuritis (pin & needles sensation in the feet )Optic neuritis & atrophy.

Pyridoxine should be given with INH

Page 19: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Drug Interactions of INH

Enzyme inhibitor of hepatic microsomal enzymes

Page 20: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Rifampin

Bactericidal

Inhibits RNA synthesis

Page 21: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Site of Action

Intracellular bacilli

Extracellular bacilli

Page 22: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Clinical uses

Treatment of TB

Prophylaxis of active TB.

Page 23: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Adverse effects

Harmless red-orange discoloration of body secretions ( saliva, sweat …..).

Hepatitis

Page 24: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Drug Interactions

Enzyme inducer of hepatic microsomal enzymes

Page 25: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Ethambutol

Bacteriostatic

Inhibits mycobacterial arabinosyl transferase ( alters the cell barrier )

Page 26: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Site Of Action

Intracellular & Extracellular bacilli

Page 27: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Clinical uses

Treatment of tuberculosis in combination with other drugs.

Page 28: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Adverse effectsImpaired visual acuity

Loss of discrimination of red-green color

Contraindicated in children under 5 years.

Page 29: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Pyrazinamide

Bactericidal

Mechanism of action is unknown .

Page 30: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Site Of Action

Active against Intracellular Bacilli

Page 31: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Clinical uses

In multidrug resistance cases.Important in short –course (6 months)

regimen.Prophylaxis of TB .

Page 32: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Adverse effects

Hepatotoxicity

Hyperuricemia ( gouty arthritis )

Page 33: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Streptomycin

BactericidalInhibits protein synthesis Active on extracellular bacilli

Page 34: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Clinical uses

Severe , life-threating form of T.B. as meningitis, disseminated disease.

Page 35: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Adverse Effects

OtotoxicityNephrotoxicityNeuromuscular block

Page 36: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Indication of 2nd line treatment

Resistance to the drugs of 1st line.Failure of clinical responseContraindication for first line drugs. Atypical tuberculosis

Page 37: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Ethionamide

Inhibits the synthesis of mycolic acid

Page 38: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Clinical uses

Treatment of TB

Page 39: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Adverse Effects

Severe gastric irritation

Neurological side effect

Page 40: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Fluoroquinolones (Ciprofloxacin )

Effective against multidrug- resistant tuberculosis.

Page 41: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Rifabutin

Inhibits RNA synthesis

Page 42: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Aminosalicylic Acid (PAS).

Bacteriostatic

Inhibits Folic acid synthesis.

Page 43: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Clinical uses

Treatment of different forms of TB.

Page 44: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

Adverse effects

GIT upset

Crystalluria

Page 45: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

TB & Pregnancy

Untreated TB represents a great risk to the pregnant woman & her fetus than the treatment itself.

First line drugs are given for 9 months in normal doses

Streptomycin is the last alternative in treatment

Page 46: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology

TB & Breast Feeding

It is not a contraindication to receive drugs , but caution is recommended

Page 47: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology
Page 48: Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology